betapharm Arzneimittel GmbH (3364323) - search results

Ireland - English - HPRA (Health Products Regulatory Authority)

ambrisentan betapharm 10 mg film-coated tablets.

betapharm arzneimittel gmbh - ambrisentan - film-coated tablet - 10 milligram(s) - other antihypertensives; ambrisentan

Ireland - English - HPRA (Health Products Regulatory Authority)

ambrisentan betapharm 5 mg film-coated tablets.

betapharm arzneimittel gmbh - ambrisentan - film-coated tablet - 5 milligram(s) - other antihypertensives; ambrisentan

European Union - English - EMA (European Medicines Agency)

azacitidine betapharm

betapharm arzneimittel gmbh - azacitidine - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastic agents - azacitidine betapharm is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 % to 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 % to 30 % blasts and multi-lineage dysplasia, according to world health organization (who) classification,aml with > 30 % marrow blasts according to the who classification.